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ts1, a mutant of MoMuLV, selectively kills T cells and neurons in the infected host resulting in neuroimmunodegeneration.
In the infected thymus there is an early increase in mitosis of thymocytes followed by rapid death, suggesting that thymocyte
death may be induced by viral mitogenic activation. Studies on thymocytes obtained from ts1-infected mice indicated that
the ts1-induced depletion of thymocytes is mediated through activation-induced death by apoptosis. To further investigate
the interaction between ts1 and thymocytes, we have established long-term primary murine thymocyte cultures by placing
the thymocytes together with thymic remnants in culture medium containing IL-2 and IL-7. These thymocytes retained their
immature phenotype and were susceptible to infection by ts1 and its parental wild-type MoMuLV. ts1-infected thymocytes
proliferated initially at accelerated rate but subsequently produced more infectious virus and died much faster than control
or MoMuLV-infected thymocytes. These in vitro studies to some extent reflect our in vivo studies reported previously.
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A major goal of our research has been to understand simulates the microenvironment of the thymus. We found
that the thymocytes in culture retained their double-posi-the pathogenic mechanisms of immunosuppression and
tive (CD4/ CD8/) immature phenotype. We also foundneurodegeneration induced by an neuroimmunopatho-
that these thymocytes could be readily infected by ts1 orgenic mutant of Moloney murine leukemia virus (Mo-
wild-type (WT) MoMuLV. To our knowledge, this is theMuLV), designated ts1 (1 –4). As in human immunodefi-
first time that primary neonatal murine thymocytes haveciency virus infection (5 –9), ts1-infection typically exhib-
been productively infected with murine retrovirus in vitroits the selective depletion of CD4/ T cells and thymocytes
and maintained for any length of time.as well as neurons (2, 10 –13). When injected intraperito-
To establish primary thymocyte cultures, single-thymo-neally, ts1 replicates in the thymus and spleen, particu-
cyte suspensions were prepared from thymus lobeslarly in thymocytes and splenic CD4/ T cells, before
taken from 1- to 2-day-old FVB/N mice. Thymocytes werespreading to the central nervous system. In the thymus,
prepared mechanically by mincing thymus and teasingduring the early phase of ts1 infection there is an in-
apart the cells with a rubber-head tissue homogenizercrease in thymocytic mitosis, which is followed by pro-
into cold RPMI-1640 medium supplemented with 2% FCSgressive and rapid thymocytic cell death particularly in
and penicillin and streptomycin. Most of the thymocytesthe cortex region (10). An ex vivo study of thymocytes
were released from the thymus in this way. The cellsfrom ts1-infected mice at 20–25 days postinfection (dpi)
were washed once with medium and plated on a plasticindicated that the ts1-induced T-cell death is the result
tissue-culture dish for 2 hr at 377. The nonadherent cellsof apoptosis (14). We also demonstrated that the killing
were then transferred to another culture dish at a densityof thymocytes by ts1 is a direct result of virus infection
of 2 1 106 cells/ml of medium containing 20% FCS, hu-of the thymus (15).
man recombinant IL-2 (50 U/ml) (Boehringer MannheimTo further investigate the specific events leading to T-
Biochemicals, Indianapolis, IN) and human recombinantcell depletion by ts1, we have established a long-term
IL-7 (30 ng/ml) (a generous gift from Sterling Winthrop,primary culture system using dissociated thymocytes.
Inc., Malvern, PA). To each of the culture dishes theThis system provides an environment that to some extent
remnant from two thymuses after the mincing and teas-
ing procedure to obtain thymocytes described above
1 To whom correspondence and reprint requests should be ad- were added. In a separate experiment, equal number
dressed. Fax: (512) 237-2444.
of thymic remnants alone (i.e., from two thymuses) was2 Current address: Columbia University, College of Physicians and
placed in each culture dish with medium only to deter-Surgeons, Department of Medicine, 650 W. 168th St., Room BB1017,
New York, New York 10032. Fax: (212) 305-1847. mine the number of cells which might release from the
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remnants into the medium during the first 2 to 3 days of
culture.
We found that by culturing thymocytes obtained from
1- to 2-day-old FVB/N mice in various concentrations
of IL-2 and IL-7 along with thymic remnants, we have
established a condition that can maintain these thymo-
cytes in cultures for over 3 weeks (Fig. 1A). During the
first 3 days of culture in this environment, there was a
50% increase in the number of viable cells (determined
by trypan blue exclusion assay). Although this viable
cell number did not increase exponentially, the fact that
we also observed a high number of dead cells (40%) by
Day 3 of culture (data not shown) indicates that a rapid
turnover of the thymocytes occurred during this period
and that the rate of cell growth is faster than the rate
of cell death at least up to 3 days after culture. More
importantly the number of viable cells in culture with IL-
2 and IL-7 and thymic remnants remained high (about
2 1 106 viable cells/ml) up to 18 days of culture. It is
possible that some thymocytes may have been released
from the remnants after we put the remnants back in
the cultures and this may have influenced our results.
This possibility, however, is not likely because in dupli-
cate culture plates in which only the thymic remnants
were placed in medium supplemented with IL-2 and
IL-7 and cultured identically to the thymocyte culture
mentioned above, the number of cells that were re-
leased from these remnants were less than 10% of the
total cell population (data not shown). Therefore, the cell
growth observed in the thymocyte suspension cultures
apparently resulted from proliferation of these cells.
However, we cannot completely rule out the possibility
that some thymocytes might be released from the thy-
mic remnants under this condition. By Day 3 of culture,
the viable cell number in thymocyte cultures with IL-7,
IL-2, and the thymic remnants, was 10-fold higher than
the viable cell number in thymocyte cultures that were
not supplemented with these cytokines or thymic rem-
nants and twofold higher than in cultures that contained
IL-2 and IL-7 but no thymic remnant. By 10 days of
culture, the cell viability was more than 10-fold higher
in the presence of IL-7, IL-2, and the thymic remnants,
than thymocyte cultures with IL-2 and IL-7 alone, and
several orders of magnitude higher than thymocyte cul-
tures without any lymphokines and thymic remnants.
These results indicate that a combination of IL-2, IL-7,
and thymic remnant provides a good growth condition
for primary thymocytes in culture. It is well known that
thymic stromal cells produce many factors that play im-
portant roles in the growth of thymocytes (16). Several
cytokines have been previously shown to augment the
growth of T cells (17 – 20). IL-2 was initially shown to be
a major primary T-cell growth factor (21), but over the
FIG. 1. Thymocytes from thymus of neonatal mice were cultured in
past several years, IL-7, which was initially isolated as different conditions as described in text. (A) Survival of cultured thymo-
a B-cell growth factor, has also been shown to be a cytes under different conditions; (B) production of virus in cultured thymo-
potent T-cell growth factor (18, 22, 23) and in the ab- cytes; and (C) survival of cultured thymocytes after virus infections.
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cytes were infected by both ts1 and WT. The virus titers
(1 1 103 –2 1 104 IU/ml) obtained from these cultures
were considerably lower than those (1 1 107 IU/ml) ob-
tained from primary culture of endothelial cells or
astrocytes (27). The overall virus production in ts1-in-
fected thymocytes, however, was consistently higher
than that of WT-infected thymocytes. By 9 dpi, viral pro-
duction in ts1-infected thymocytes reached 2 1 104 IU/
ml and exceeded that of WT-infected thymocytes by
about 10-fold.
FIG. 2. Fluorescence-activated cell sorting analysis of the primary To assess whether ts1 and WT exert any cytopathic
thymocyte cultures using labeled antibodies against Thy1.1 and CD4 effects on the thymocytes in vitro and whether they are
or Thy1.1 and CD8 antibodies. Single-cell suspensions were prepared comparable, the number of viable cells was determinedas described in text. 2 1 105 cells in a volume of 100 ml was incubated
every 2–3 days and assayed by trypan blue exclusion.for 30 min at 47 with fluorescein-conjugated anti-Thy1.1 (Sigma), and
As shown in Fig. 1C, by the first 3 dpi, ts1-infected thymo-PE-conjugated anti-CD4 (L3T4) and anti-CD8 (Lyt 2.2) (Boehringer
Mannheim Biochemicals). cytes grew faster than WT-infected or uninfected thymo-
cytes. However, the number of viable thymocytes in-
fected with ts1 declined much faster after the initial acti-
sence of other cytokines to induce IL-2 and IL-4 secre- vation. By 15 dpi, ts1-infected thymocyte number was
tion (20, 24, 25). Watson et al. (20) have reported long- about sixfold less than that of the uninfected control cells,
term T-cell growth using intact fetal thymus lobes in the and about fourfold less than that of WT-infected cells
presence of IL-2 and IL-7. However, long term growth (Fig. 1C). These results indicate that both ts1 and WT
of thymocytes from neonatal or adult mice has not been induced thymocytic cell death, but that ts1 after the initial
reported. activation induced T cell killing at a much faster rate than
Fluorescence-activated cell sorter analysis of these did WT virus. This data is in agreement with the results
thymocyte cultures at 2 to 3 days after culture with la- of our previous ex vivo studies of thymocytes isolated
beled antibodies against various T-cell antigens (Thy 1.1, from ts1- or WT-infected mice (15).
CD4, and CD8) showed that these thymocyte cultures Our system of long-term cultures of thymocytes from
contained largely CD4//CD8/ double-positive T cells postnatal mice reported here not only reflect the capacity
(Fig. 2), thus retaining their phenotype in vivo (14). Al- of culture primary murine thymocytes to function in vitro
though we did notice a slight increase in the percentage but also correlate to what happens to these cells in vivo
of single-positive cells (CD4/ or CD8/) as the cultures during ts1 infection. This system may also serve as a tool
grew older (data not shown), the vast majority (75%) of to elucidate the mechanism(s) underlying ts1-MoMuLV-
the cells retained their double-positive phenotype for at mediated thymocyte death. Furthermore, these primary
least up to 10 days after culture. thymocyte cultures will also be useful in studies on the
To assess whether these primary cultures of thymo- mechanisms involved in controlling the fates of T cells
cytes are susceptible to ts1 and WT infection, freshly during development.
isolated neonatal thymocyte suspension cultures as de-
scribed above were diluted to a density of 2 1 106 cells/ ACKNOWLEDGMENTS
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